Biotricity (OTC:BTCY) reported quarterly earnings results on February 11, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per share of $-0.04,…
Biotricity (OTC:BTCY) reported quarterly earnings results on February 11, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $-0.04, beating the consensus estimate of $-0.08 by $0.04 per share. Revenue came in at $4.0M, missing the estimate of $4.1M.
Biotricity's stock moved following the earnings release. The stock currently trades at $0.24 with a market capitalization of $9.7M.
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Current market data
OTC · BTCY
$0.12
Up: +$0.01 · +5.45%
Live quote updated
Keep reading
sec_filing ·
sec_filing ·
sec_filing ·
